Clinical guideline for minimally invasive treatment of palmar hyperhidrosis in China (2021)
- VernacularTitle:中国手汗症微创治疗临床指南（2021 年版）
- Author:
Yuanrong TU
1
;
Yanguo LIU
2
,
3
Author Information
- Collective Name:Writing Board of Clinical Guidelines for Minimally Invasive Treatment of Palmar Hyperhidrosis in China
- Publication Type:Journal Article
- Keywords: Palmar hyperhidrosis; endoscopic thoracic sympathicotomy; compensatory hyperhidrosis; guideline
- From: Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2021;28(10):1133-1139
- CountryChina
- Language:Chinese
- Abstract: This guideline systematically reviewed and summarized the 20 years' clinical and basic research experience of minimally invasive treatment of palmar hyperhidrosis (PH) in China, and discussed the hot and difficult issues of minimally invasive treatment of PH. We have formed a new consensus of PH in terms of its definition, clinical manifestations, diagnostic criteria and classification, surgical indications and contraindications, surgical procedures and management of complications, especially in the area of postoperative compensatory hyperhidrosis (CH). This guideline confirmed that endoscopic thoracic sympathicotomy (ETS) was the most effective treatment for PH and that CH was the most common side effect. In order to reduce the incidence of CH, eliminate patient's distress and improve patient's satisfaction, the guideline emphasized that the keys to prevent CH were to pay attention to pre-operative interview, communicate with patients, select patients carefully, avoid the enlargement of operative indication and optimize operative procedure. This guideline also introduced the advantages and disadvantages of various methods to reduce the incidence of CH. We provided this authoritative guidance document in order to avoid the surgical risk, strengthen the perioperative management and improve the sugery effect.
